buformin has been researched along with Metastase in 1 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isono, T | 1 |
| Chano, T | 1 |
| Yonese, J | 1 |
| Yuasa, T | 1 |
1 other study available for buformin and Metastase
| Article | Year |
|---|---|
Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas.
Topics: Acids; Buformin; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Epoxy Compounds; Flow Cytometr | 2016 |